• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Hypopigmentation Secondary to Eczema

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 9 No 9
Volume 9
Issue 9

The areas of hypopigmentation on this 4-month-old girl are sequelae of eczema. The rash had developed on the infant’s upper extremities in the bilateral antecubital and popliteal fossae at 1 month of age. Her cheeks were also affected, although only slightly. Her initial diet consisted of regular infant formula. This was switched to soy formula, which she vomited. She was then given a lactose-free formula, which she tolerated well.

The areas of hypopigmentation on this 4-month-old girl are sequelae of eczema. The rash had developed on the infant's upper extremities in the bilateral antecubital and popliteal fossae at 1 month of age. Her cheeks were also affected, although only slightly. Her initial diet consisted of regular infant formula. This was switched to soy formula, which she vomited. She was then given a lactose-free formula, which she tolerated well.

In this infant, the hypopigmented areas corresponded exactly to the sites affected by eczema. This made other causes of hypopigmentation, such as impetigo, unlikely. Postinflammatory hypopigmentation after an episode of eczema is unusual; it may be more common, or more noticeable, in persons with racially pigmented skin. In this case, the location of the eczema in the flexors and its duration may have been contributing factors.

The infant was treated with triamcinolone 0.025% cream, applied to the affected areas 3 times daily, and alclometasone dipropionate 0.05%, applied to the cheeks twice daily. The parents can be reassured that normal pigmentation will return with the resolution of the eczema.

Related Videos
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.